{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:22:55Z","timestamp":1794997375515,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-NR077237"],"award-info":[{"award-number":["RS-2023-NR077237"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00411137"],"award-info":[{"award-number":["RS-2024-00411137"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00441157"],"award-info":[{"award-number":["RS-2024-00441157"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CNUH-GIST research collaboration grant funded by the Gwangju Institute of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumor microenvironment (TME) plays a central role in cancer progression and metastasis. A key feature of the TME is extracellular acidity, which promotes disease progression, immune evasion, and drug resistance. Tumor acidity is increasingly recognized as a critical factor in cancer development and a negative prognostic indicator. Here, we demonstrate that the membrane glycoprotein dysadherin promotes colorectal cancer (CRC) malignancy by modulating TME acidity. Comprehensive bioinformatics and pathological analyses of CRC patient samples revealed that increased tumor acidity is a hallmark of CRC progression and strongly correlates with high expression of dysadherin. Functional studies confirmed that dysadherin enhances malignant traits, particularly under acidic conditions. Mechanistically, dysadherin activates the integrin\/FAK\/STAT3 signaling pathway, leading to the upregulation of carbonic anhydrase 9 (CA9). CA9 facilitates proton export, contributing to extracellular acidification while maintaining intracellular pH homeostasis, thereby enabling cancer cells to survive and thrive in acidic environments. In a murine liver metastasis model, dysadherin deletion impaired cellular adaptation to the acidic TME and markedly attenuated metastatic colonization, whereas restoring CA9 expression effectively rescued metastatic potential. Overall, our findings identify the dysadherin\/CA9 axis as a potential therapeutic target in CRC and provide new insights into how tumors exploit acidosis to drive malignant development and progression.<\/jats:p>","DOI":"10.1038\/s41392-025-02543-x","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:03:29Z","timestamp":1768435409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The dysadherin\/carbonic anhydrase 9 axis shapes an acidic tumor microenvironment to promote colorectal cancer progression"],"prefix":"10.1038","volume":"11","author":[{"given":"Choong-Jae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Ji","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-El","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Hoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Ye","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9753-6095","authenticated-orcid":false,"given":"Jeong-Seok","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"2543_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban, R. et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun. Signal 18, 1\u201319 (2020).","journal-title":"Cell Commun. Signal"},{"key":"2543_CR2","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw, D. C. & Shevde, L. A. The tumor microenvironment innately modulates cancer progression. Cancer Res. 79, 4557\u20134566 (2019).","journal-title":"Cancer Res."},{"key":"2543_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"2543_CR4","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.3390\/cancers12123802","volume":"12","author":"RC Augustin","year":"2020","unstructured":"Augustin, R. C., Delgoffe, G. M. & Najjar, Y. G. Characteristics of the tumor microenvironment that influence immune cell functions: hypoxia, oxidative stress, metabolic alterations. Cancers 12, 3802 (2020).","journal-title":"Cancers"},{"key":"2543_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","volume":"3","author":"S Pennacchietti","year":"2003","unstructured":"Pennacchietti, S. et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer cell 3, 347\u2013361 (2003).","journal-title":"Cancer cell"},{"key":"2543_CR6","doi-asserted-by":"crossref","unstructured":"Hill, R. P., Marie-Egyptienne D. T. & Hedley D. W. Cancer stem cells, hypoxia and metastasis. Semin Radiat. Oncol. 19, 106\u2013111 (2009).","DOI":"10.1016\/j.semradonc.2008.12.002"},{"key":"2543_CR7","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1128\/MCB.24.7.2875-2889.2004","volume":"24","author":"JT Erler","year":"2004","unstructured":"Erler, J. T. et al. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and-independent mechanisms and contributes to drug resistance. Mol. Cell Biol. 24, 2875\u20132889 (2004).","journal-title":"Mol. Cell Biol."},{"key":"2543_CR8","doi-asserted-by":"crossref","unstructured":"Muz, B., de la Puente, P., Azab, F. & Kareem Azab, A. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 3, 83\u201392 (2015).","DOI":"10.2147\/HP.S93413"},{"key":"2543_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1172\/JCI40027","volume":"120","author":"KM Rouschop","year":"2010","unstructured":"Rouschop, K. M. et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Investig. 120, 127\u2013141 (2010).","journal-title":"J. Clin. Investig."},{"key":"2543_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature04871","volume":"441","author":"J Pouyss\u00e9gur","year":"2006","unstructured":"Pouyss\u00e9gur, J., Dayan, F. & Mazure, N. M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437\u2013443 (2006).","journal-title":"Nature"},{"key":"2543_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tcb.2014.06.001","volume":"24","author":"D Ackerman","year":"2014","unstructured":"Ackerman, D. & Simon, M. C. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol. 24, 472\u2013478 (2014).","journal-title":"Trends Cell Biol."},{"key":"2543_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/BF01712130","volume":"2","author":"O Warburg","year":"1923","unstructured":"Warburg, O. & Minami, S. Versuche an \u00fcberlebendem carcinom-gewebe. Klin. Wochenschr. 2, 776\u2013777 (1923).","journal-title":"Klin. Wochenschr."},{"key":"2543_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cmet.2020.03.001","volume":"31","author":"K Lund\u00f8","year":"2020","unstructured":"Lund\u00f8, K., Trauelsen, M., Pedersen, S. F. & Schwartz, T. W. Why Warburg works: lactate controls immune evasion through GPR81. Cell Metab. 31, 666\u2013668 (2020).","journal-title":"Cell Metab."},{"key":"2543_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"2543_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.979154","volume":"12","author":"A Bogdanov","year":"2022","unstructured":"Bogdanov, A. et al. Tumor acidity: from hallmark of cancer to target of treatment. Front Oncol. 12, 979154 (2022).","journal-title":"Front Oncol."},{"key":"2543_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet, C. & Feron, O. Tumour acidosis: from the passenger to the driver\u2019s seat. Nat. Rev. Cancer 17, 577\u2013593 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"2543_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105796","volume":"125","author":"T Zheng","year":"2020","unstructured":"Zheng, T., J\u00e4\u00e4ttel\u00e4, M. & Liu, B. pH gradient reversal fuels cancer progression. Int. J. Biochem Cell Biol. 125, 105796 (2020).","journal-title":"Int. J. Biochem Cell Biol."},{"key":"2543_CR18","doi-asserted-by":"crossref","unstructured":"Omran Z., Scaife P., Stewart S., Rauch C. Physical and biological characteristics of multi drug resistance (MDR): an integral approach considering pH and drug resistance in cancer. Semin Cancer Biol. 43, 42\u201348 (2017).","DOI":"10.1016\/j.semcancer.2017.01.002"},{"key":"2543_CR19","doi-asserted-by":"crossref","unstructured":"Huber, V. et al. Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol. 43, 74\u201389 (2017).","DOI":"10.1016\/j.semcancer.2017.03.001"},{"key":"2543_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70396-1","volume":"10","author":"N Piasentin","year":"2020","unstructured":"Piasentin, N., Milotti, E. & Chignola, R. The control of acidity in tumor cells: a biophysical model. Sci. Rep. 10, 13613 (2020).","journal-title":"Sci. Rep."},{"key":"2543_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.876195","volume":"13","author":"D Zhu","year":"2022","unstructured":"Zhu, D. et al. Lactate: A regulator of immune microenvironment and a clinical prognosis indicator in colorectal cancer. Front. Immunol. 13, 876195 (2022).","journal-title":"Front. Immunol."},{"key":"2543_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.884448","volume":"12","author":"S-p Liu","year":"2022","unstructured":"Liu, S. -p et al. LAMP2 as a biomarker related to prognosis and immune infiltration in esophageal cancer and other cancers: a comprehensive pan-cancer analysis. Front. Oncol. 12, 884448 (2022).","journal-title":"Front. Oncol."},{"key":"2543_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1073\/pnas.012425299","volume":"99","author":"Y Ino","year":"2002","unstructured":"Ino, Y., Gotoh, M., Sakamoto, M., Tsukagoshi, K. & Hirohashi, S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc. Natl. Acad. Sci. USA 99, 365\u2013370 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2543_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/sj.bjc.6600778","volume":"88","author":"S Aoki","year":"2003","unstructured":"Aoki, S. et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br. J. Cancer 88, 726\u2013732 (2003).","journal-title":"Br. J. Cancer"},{"key":"2543_CR25","doi-asserted-by":"publisher","first-page":"6989","DOI":"10.1158\/0008-5472.CAN-04-1166","volume":"64","author":"T Shimamura","year":"2004","unstructured":"Shimamura, T. et al. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res. 64, 6989\u20136995 (2004).","journal-title":"Cancer Res."},{"key":"2543_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1349-7006.2012.02302.x","volume":"103","author":"YK Lee","year":"2012","unstructured":"Lee, Y. K. et al. Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation. Cancer Sci. 103, 1280\u20131289 (2012).","journal-title":"Cancer Sci."},{"key":"2543_CR27","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.7150\/thno.72354","volume":"12","author":"S-Y Park","year":"2022","unstructured":"Park, S.-Y. et al. Dysadherin awakens mechanical forces and promotes colorectal cancer progression. Theranostics 12, 4399 (2022).","journal-title":"Theranostics"},{"key":"2543_CR28","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-0633-03","volume":"10","author":"Y Shimada","year":"2004","unstructured":"Shimada, Y. et al. Clinical significance of dysadherin expression in gastric cancer patients. Clin. Cancer Res. 10, 2818\u20132823 (2004).","journal-title":"Clin. Cancer Res."},{"key":"2543_CR29","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.7150\/ijbs.86699","volume":"20","author":"C-J Lee","year":"2024","unstructured":"Lee, C.-J. et al. The dysadherin\/FAK axis promotes individual cell migration in colon cancer. Int. J. Biol. Sci. 20, 2356\u20132369 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"2543_CR30","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-06-0825","volume":"66","author":"J-S Nam","year":"2006","unstructured":"Nam, J.-S. et al. Chemokine (CC motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res. 66, 7176\u20137184 (2006).","journal-title":"Cancer Res."},{"key":"2543_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54920-9","volume":"15","author":"C-J Lee","year":"2024","unstructured":"Lee, C.-J. et al. The dysadherin\/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression. Nat. Commun. 15, 10422 (2024).","journal-title":"Nat. Commun."},{"key":"2543_CR32","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1158\/0008-5472.CAN-08-1839","volume":"68","author":"N Rohwer","year":"2008","unstructured":"Rohwer, N. et al. Hypoxia-inducible factor 1\u03b1 mediates anoikis resistance via suppression of \u03b15 integrin. Cancer Res. 68, 10113\u201310120 (2008).","journal-title":"Cancer Res."},{"key":"2543_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2007.02.018","volume":"255","author":"J-S Nam","year":"2007","unstructured":"Nam, J.-S., Hirohashi, S. & Wakefield, L. M. Dysadherin: a new player in cancer progression. Cancer Lett. 255, 161\u2013169 (2007).","journal-title":"Cancer Lett."},{"key":"2543_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer, E. & Pedersen, S. F. The acidic tumor microenvironment as a driver of cancer. Annu. Rev. Physiol. 82, 103\u2013126 (2020).","journal-title":"Annu. Rev. Physiol."},{"key":"2543_CR35","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12272-019-01185-2","volume":"42","author":"MT Lebelo","year":"2019","unstructured":"Lebelo, M. T., Joubert, A. M. & Visagie, M. H. Warburg effect and its role in tumourigenesis. Arch. Pharm. Res. 42, 833\u2013847 (2019).","journal-title":"Arch. Pharm. Res."},{"key":"2543_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","volume":"38","author":"S Pastorekova","year":"2019","unstructured":"Pastorekova, S. & Gillies, R. J. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metastasis Rev. 38, 65\u201377 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"2543_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/glycob\/cwg065","volume":"13","author":"H Tsuiji","year":"2003","unstructured":"Tsuiji, H., Takasaki, S., Sakamoto, M., Irimura, T. & Hirohashi, S. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell\u2013cell adhesion. Glycobiology 13, 521\u2013527 (2003).","journal-title":"Glycobiology"},{"key":"2543_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-016-0157-7","volume":"14","author":"NP Visavadiya","year":"2016","unstructured":"Visavadiya, N. P. et al. Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3. Cell Commun. Signal. 14, 1\u201315 (2016).","journal-title":"Cell Commun. Signal."},{"key":"2543_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1182\/blood.2021011563","volume":"139","author":"CH Man","year":"2022","unstructured":"Man, C. H. et al. Proton export alkalinizes intracellular pH and reprograms carbon metabolism to drive normal and malignant cell growth. Blood 139, 502\u2013522 (2022).","journal-title":"Blood"},{"key":"2543_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10286","volume":"7","author":"IY Bae","year":"2022","unstructured":"Bae, I. Y., Choi, W., Oh, S. J., Kim, C. & Kim, S. H. TIMP-1-expressing breast tumor spheroids for the evaluation of drug penetration and efficacy. Bioeng. Transl. Med. 7, e10286 (2022).","journal-title":"Bioeng. Transl. Med."},{"key":"2543_CR41","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.3390\/cancers14143321","volume":"14","author":"I Kim","year":"2022","unstructured":"Kim, I., Choi, S., Yoo, S., Lee, M. & Kim, I.-S. Cancer-associated fibroblasts in the hypoxic tumor microenvironment. Cancers 14, 3321 (2022).","journal-title":"Cancers"},{"key":"2543_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol. Cancer 22, 159 (2023).","journal-title":"Mol. Cancer"},{"key":"2543_CR43","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1038\/s44318-024-00235-w","volume":"43","author":"R Vuillefroy de Silly","year":"2024","unstructured":"Vuillefroy de Silly, R., Pericou, L., Seijo, B., Crespo, I. & Irving, M. Acidity suppresses CD8+ T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling. EMBO J. 43, 4922\u20134953 (2024).","journal-title":"EMBO J."},{"key":"2543_CR44","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Suppression of the METTL3-m6A-integrin \u03b21 axis by extracellular acidification impairs T cell infiltration and antitumor activity. Cell Rep. 43, 113796 (2024).","DOI":"10.1016\/j.celrep.2024.113796"},{"key":"2543_CR45","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1158\/0008-5472.CAN-15-2630","volume":"76","author":"A Filatova","year":"2016","unstructured":"Filatova, A. et al. Acidosis acts through HSP90 in a PHD\/VHL-independent manner to promote HIF function and stem cell maintenance in glioma. Cancer Res. 76, 5845\u20135856 (2016).","journal-title":"Cancer Res."},{"key":"2543_CR46","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1038\/oncsis.2016.81","volume":"5","author":"B Chen","year":"2016","unstructured":"Chen, B., Liu, J., Ho, T., Ding, X. & Mo, Y. ERK-mediated NF-\u03baB activation through ASIC1 in response to acidosis. Oncogenesis 5, e279\u2013e279 (2016).","journal-title":"Oncogenesis"},{"key":"2543_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2014.10.001","volume":"146","author":"BY Lee","year":"2015","unstructured":"Lee, B. Y., Timpson, P., Horvath, L. G. & Daly, R. J. FAK signaling in human cancer as a target for therapeutics. Pharm. Ther. 146, 132\u2013149 (2015).","journal-title":"Pharm. Ther."},{"key":"2543_CR48","doi-asserted-by":"publisher","first-page":"e15746","DOI":"10.1371\/journal.pone.0015746","volume":"6","author":"RK Paradise","year":"2011","unstructured":"Paradise, R. K., Lauffenburger, D. A. & Van Vliet, K. J. Acidic extracellular pH promotes activation of integrin \u03b1v\u03b23. PloS ONE 6, e15746 (2011).","journal-title":"PloS ONE"},{"key":"2543_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-13-89","volume":"13","author":"Y Kato","year":"2013","unstructured":"Kato, Y. et al. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 13, 1\u20138 (2013).","journal-title":"Cancer Cell Int."},{"key":"2543_CR50","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/cells11030544","volume":"11","author":"AS Yamagata","year":"2022","unstructured":"Yamagata, A. S. et al. Transcriptomic response to acidosis reveals its contribution to bone metastasis in breast cancer cells. Cells 11, 544 (2022).","journal-title":"Cells"},{"key":"2543_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3892\/ijo.2023.5584","volume":"63","author":"W-Y Shie","year":"2023","unstructured":"Shie, W.-Y. et al. Acidosis promotes the metastatic colonization of lung cancer via remodeling of the extracellular matrix and vasculogenic mimicry. Int. J. Oncol. 63, 136 (2023).","journal-title":"Int. J. Oncol."},{"key":"2543_CR52","doi-asserted-by":"publisher","first-page":"83088","DOI":"10.18632\/oncotarget.20236","volume":"8","author":"J-S Yang","year":"2017","unstructured":"Yang, J.-S. et al. Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells. Oncotarget 8, 83088 (2017).","journal-title":"Oncotarget"},{"key":"2543_CR53","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41416-020-0756-3","volume":"122","author":"A Giatromanolaki","year":"2020","unstructured":"Giatromanolaki, A., Harris, A. L., Banham, A. H., Contrafouris, C. A. & Koukourakis, M. I. Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+ T-cell tumour stroma infiltration. Br. J. Cancer 122, 1205\u20131210 (2020).","journal-title":"Br. J. Cancer"},{"key":"2543_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19627-7","volume":"11","author":"M Tian","year":"2020","unstructured":"Tian, M. et al. IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of \u03b2-catenin. Nat. Commun. 11, 5762 (2020).","journal-title":"Nat. Commun."},{"key":"2543_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.102021","volume":"4","author":"M O\u2019Brien","year":"2023","unstructured":"O\u2019Brien, M., Ernst, M. & Poh, A. R. An intrasplenic injection model of pancreatic cancer metastasis to the liver in mice. STAR Protoc. 4, 102021 (2023).","journal-title":"STAR Protoc."},{"key":"2543_CR56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jhep.2010.06.026","volume":"54","author":"J-R Park","year":"2011","unstructured":"Park, J.-R. et al. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells. J. Hepatol. 54, 122\u2013131 (2011).","journal-title":"J. Hepatol."},{"key":"2543_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2014.01.005","volume":"178","author":"EE Paoli","year":"2014","unstructured":"Paoli, E. E. et al. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. J. Control Release 178, 108\u2013117 (2014).","journal-title":"J. Control Release"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02543-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:03:31Z","timestamp":1768435411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02543-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2543"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02543-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}